Medicare Enrolled
Dr. Christopher Dibello, M.D.
Pulmonary Disease · New Smyrna Beach, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dibello from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dibello?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dibello
Dr. Christopher Dibello is a pulmonary disease specialist in New Smyrna Beach, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Dibello performed 19,592 Medicare services across 5,151 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dibello received a total of $42,205 from 54 pharmaceutical and/or device companies across 635 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dibello is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 1% volume in FL
$42,205 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 107805 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗19,592
Medicare services
Top 1% in FL for pulmonary disease
5,151
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,088 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
7,709 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,863 | $96 | $248 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,490 | $94 | $200 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
1,036 | $0 | $1 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
928 | $28 | $74 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
787 | $48 | $128 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
758 | $12 | $30 |
| Injection, levofloxacin, 250 mg | 629 | $1 | $3 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
592 | $41 | $104 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
592 | $42 | $110 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
481 | $62 | $140 |
| Ertapenem sodium injection, 500 mg An injection of ertapenem sodium, an antibiotic medication, administered at a dose of 500 mg. |
341 | $11 | $114 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
270 | $11 | $28 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
262 | $9 | $26 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
227 | $122 | $328 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
177 | $137 | $387 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
158 | $170 | $546 |
| Injection, furosemide, up to 20 mg | 125 | $0 | $2 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
98 | $103 | $264 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $133 | $352 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
19 | $102 | $264 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
12 | $13 | $33 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
11 | $30 | $36 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.0% high complexity
56.8% medium
39.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$42,205
Total received (2018-2024)
Avg $6,029/year across 7 years
Top 7% in FL for pulmonary disease
54
Companies
635
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$33,161 (78.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,044 (21.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,819
2023
$6,232
2022
$2,796
2021
$9,849
2020
$3,244
2019
$6,637
2018
$11,628
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$29,129
Intuitive Surgical, Inc.
$3,887
AstraZeneca Pharmaceuticals LP
$2,311
GlaxoSmithKline, LLC.
$1,906
Philips Electronics North America Corporation
$629
GENZYME CORPORATION
$403
Regeneron Healthcare Solutions, Inc.
$381
Ethicon Inc.
$357
Amgen Inc.
$342
Boston Scientific Corporation
$283
Mylan Specialty L.P.
$259
Veran Medical Technologies, Inc.
$256
Grifols USA, LLC
$171
Allergan Inc.
$146
JAZZ PHARMACEUTICALS INC.
$125
Insmed, Inc.
$113
Astute Medical, Inc.
$111
AbbVie Inc.
$105
Takeda Pharmaceuticals U.S.A., Inc.
$97
Novartis Pharmaceuticals Corporation
$86
Inogen, Inc.
$83
Teva Pharmaceuticals USA, Inc.
$80
Sunovion Pharmaceuticals Inc.
$69
ABBVIE INC.
$55
SANOFI-AVENTIS U.S. LLC
$55
UCB, Inc.
$54
Electromed, Inc.
$50
Merck Sharp & Dohme LLC
$49
Baxter Healthcare
$45
Astellas Pharma US Inc
$39
Paratek Pharmaceuticals, Inc.
$36
Covidien LP
$35
Circassia Pharmaceuticals Inc
$34
Actelion Pharmaceuticals US, Inc.
$33
Genentech USA, Inc.
$29
SK Life Science, Inc.
$28
Merck Sharp & Dohme Corporation
$28
Inari Medical, Inc.
$28
Optinose US, Inc.
$24
Janssen Pharmaceuticals, Inc
$24
Microtransponder, Inc.
$23
Resmed Corp
$20
Philips North America LLC
$20
Mallinckrodt Hospital Products Inc.
$18
Tactile Systems Technology Inc
$18
Lundbeck LLC
$17
Hikma Pharmaceuticals USA
$16
INOGEN, INC.
$15
BOSTON SCIENTIFIC CORPORATION
$14
Advanced Respiratory, Inc
$14
Fisher & Paykel Healthcare Inc
$14
Allergan, Inc.
$13
E.R. Squibb & Sons, L.L.C.
$12
Mallinckrodt LLC
$12
Top 3 companies account for 83.7% of total payments
Associated products mentioned in payments ›
(8744) Trilogy Evo · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AFINITOR · AIMOVIG · AIRSENSE · AIRSUPRA · ALAIR · ANORO · ANORO ELLIPTA · AVYCAZ · Acquire · AirDuo Digihaler · Arikayce · Austedo XR · BEVESPI AEROSPHERE · BOTOX · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · Cresemba · DUPIXENT · Da Vinci Surgical System · Dymista · ELIQUIS · Edge Navigation · Esbriet · FARXIGA · FASENRA · FISHER & PAYKEL HEALTHCARE · FLOWTRIEVER CATHETER · Flexitouch Plus · GLASSIA · Hillrom - Life 2000 Ventilation System · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · ION · InogenOne · KEYTRUDA · LONHALA MAGNAIR · Life 2000 Ventilation System · Monarch Platform · NUCALA · NUZYRA · Nephrocheck · OFEV · OPSUMIT · Prolastin-C · Prolastin-C Liquid · Ryaltris · Rystiggo · S · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · Spin · SpyGlass Discover · Superion · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · Trilogy 100 · UBRELVY · Utibron · VYEPTI · Wellcentive Undiv · XOLAIR · XYWAV · Xhance · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (79%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for pulmonary disease in FL.
Equivalent to $215 per 100 Medicare services performed
Geographic Context
Pulmonary diseases within 10 mi
11
Per 100K population
1.9
County median income
$66,581
Nearest hospital
HALIFAX HEALTH MEDICAL CENTER
13.7 mi
13.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Dibello is a clinical cardiology specialist, with above-average Medicare volume (top 1% in FL), with speaking/promotional industry engagement in the top 7% of FL peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Dibello experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Dibello performed 7,709 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dibello receive payments from pharmaceutical companies?
Yes. Dr. Dibello received a total of $42,205 from 54 companies across 635 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dibello's costs compare to other pulmonary diseases in New Smyrna Beach?
Dr. Dibello's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dibello) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in New Smyrna Beach
Browse pulmonary diseases in New Smyrna Beach ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in FL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in FL
Which FL pulmonary diseases receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology